Histological pattern of focal segmental glomerulosclerosis and its clinical correlation
Keywords:FSGS, Histological pattern, Renal biopsy
Background: Focal segmental glomerulosclerosis (FSGS) is a pattern of injury and it has five histological subtypes with varying prognosis and therapeutic response. Our aim was to study the pattern of primary FSGS in our population along with their clinicopathological characteristics.
Methods: This is a 2-year retrospective, single centre cohort, observational study. All adult patients with primary FSGS were identified.
Results: There were 51 patients of primary FSGS. The mean age of patients was 37.2±15.3 years with overall male dominance. The clinical presentations were nephrotic syndrome (88.2%), proteinuria with hematuria (11.7%), hypertension (47.05%) and renal insufficiency (60%). FSGS-NOS were seen in 26 patients, tip variant in 11, perihilar in 6, cellular variant in 6 and collapsing variant in 2 patients. The mean age of collapsing variant was significantly less than others (20.5±9.1 years vs 37.2±15.3 years). Massive proteinuria was seen in collapsing and tip variant significantly higher than rest of the variants and tip variant had the least degree of interstitial fibrosis and tubular atrophy.
Conclusions: FSGS is a pattern of injury which shows histological variations. Although it most commonly affects males, tip and cellular variants show female preponderance. Massive proteinuria was mostly seen in collapsing and tip variants and the features of chronicity were mostly seen in tip variant. Larger studies are required for the differences in treatment protocols and prognosis of different variants.
Churg J, Habib R, White RH: Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney Disease in Children. Lancet. 1970;760:1299-302.
Korbet SM. Primary focal segmental glomerulosclerosis. In: Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector’s The Kidney. 2nd Ed., edited by Brady RJ, Wilcox CS, Philadelphia, W.B. Saunders Company. 2003; 223-36.
Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int. 2002;62:2301-10.
Meyrier A. E pluribus unum: The riddle of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23:135-40.
Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int. 2006;69(5):920-6.
Taneda S, Honda K, Uchida K, Nitta K, Yumura W, Oda H et al. Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis. Int Urol Nephrol. 2012;44(1):183-96.
Cattran DC, Feehally J, Cook HT. Kidney disease. Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. 2012;2:139-274.
Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol. 2004;15(8):2169-77.
Agarwal R. Defining end-stage renal disease in clinical trials: a framework for adjudication. Nephrol Dial Transplant. 2015; 31:864-7.
Mian AN, Schwartz GJ. Measurement and Estimation of Glomerular Filtration Rate in Children. Adv Chronic Kidney Dis. 2017;24(6):348-56.
D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23(2):117-34.
Rydel JJ, Korbet SM, Borok RZ, Schwartz MM. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis. 1995;25(4):534-42.
Trivedi M, Pasari A, Chowdhury AR, Abraham A, Pandey R. Tip variant of focal segmental glomerulosclerosis: is it truly a benign variant? Renal Failure. 2015;37(5):763-8.